Chargement en cours...
Application of a Policy Framework for the Public Funding of Drugs for Rare Diseases
BACKGROUND: In many countries, decisions about the public funding of drugs are preferentially based on the results of randomized trials. For truly rare diseases, such trials are not typically available, and approaches by public payers are highly variable. In view of this, a policy framework intended...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer US
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4124122/ https://ncbi.nlm.nih.gov/pubmed/25029973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11606-014-2885-y |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|